Insulet
PODD
HK$1,989
Share price
0.37%
Change (1 day)
46.05%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.
Insulet (PODD) - P/B ratio
P/B ratio as of April 2025 : 14.9
According to Insulet's latest financial reports the company has a price-to-book ratio of 8.69267.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Insulet - P/B ratio (from 2007 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | 15.3 | -25.77% |
| 2023-12-31 | 20.7 | -51.82% |
| 2022-12-31 | 42.9 | 30.1% |
| 2021-12-31 | 33.0 | 18.14% |
| 2020-12-31 | 27.9 | -80.25% |
| 2019-12-31 | 141 | 538.77% |
| 2018-12-31 | 22.1 | -12.61% |
| 2017-12-31 | 25.3 | -26.08% |
| 2016-12-31 | 34.3 | -45.82% |
| 2015-12-31 | 63.2 | 104.45% |
| 2014-12-31 | 30.9 | 89.33% |
| 2013-12-31 | 16.3 | -29.67% |
| 2012-12-31 | 23.2 | 115.35% |
| 2011-12-31 | 10.8 | 1.43% |
| 2010-12-31 | 10.6 | 4.26% |
| 2009-12-31 | 10.2 | 44.87% |
| 2008-12-31 | 7.04 | 7.95% |
| 2007-12-31 | 6.52 | |
| 2006-12-31 | N/A | |
| 2005-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | P/B ratio differencediff. | Country |
|---|---|---|---|
 | 1.75 | -88.23% | 🇺🇸 USA |
 | 4.48 | -69.85% | 🇺🇸 USA |
 | 12.9 | -13.14% | 🇺🇸 USA |
 | 5.18 | -65.16% | 🇺🇸 USA |
 | 4.57 | -69.25% | 🇺🇸 USA |
 | 2.13 | -85.67% | 🇮🇪 Ireland |
 | 47.6 | 220.55% | 🇺🇸 USA |